Navigation Links
Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets
Date:12/4/2013

BURLINGTON, Mass., Dec. 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next six decades prevalent cases of several diseases that represent commercially important opportunities for drug developers will peak and then decline. The Strategic Insights report entitled Timing Matters: Shifting Opportunities for Drug Developers as Global Populations Age, finds that Germany, Japan and Russia will be the first markets to experience a peak in cases of chronic obstructive pulmonary disease, major depressive disorder, age-related macular degeneration and Alzheimer's disease.

The report examines the peak cases phenomenon in key commercial disease markets of Brazil, urban China, Germany, Japan, Russia and the United States, and explores the interaction between population size, demographics and peak cases. Because markets are at different stages of the population aging, peak cases will be reached at different times across markets and diseases.

According to the report, diseases with a higher prevalence in younger populations are more sensitive to the reductive impact of aging populations. For example, prevalent cases of major depressive disorder will decline owing to aging demographics across five of the six markets examined.

"Disease populations — and therefore opportunities for drug developers — will continue to expand for diseases with their highest prevalence in older age-groups. For example, prevalent cases in Alzheimer's disease will increase by more than 800 percent in urban China between 2012 and 2072," said Decision Resources Senior Epidemiologist Donal Minihan, Ph.D. "The United States is largely immune to the peak cases phenomenon because its immigration and reproductive rate will maintain an increasing population with a balanced spread across age-groups."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
2. Medical Device Market Opportunities in Germany, 2012
3. PELOBIOTECH to Distribute ReachBios Products in Germany, Austria and Switzerland
4. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
5. Japanese Fund Moves Quickly to Invest in Promising Technology Against Malaria, Tuberculosis And Chagas Disease
6. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
7. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
8. Japan Pharmaceutical Market Outlook
9. Japan Vietnam Medical Instrument Company Ranked as One of Top 3 Companies in Vietnam
10. Japan Vietnam Medical Instrument Company Announces $7M Capital Raise
11. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
(Date:11/30/2016)... 2016 Research and Markets has announced the ... 2017 - MedCore" report to their offering. ... , , The cerebrospinal ... In healthy individuals, it is circulated though the brain and its ventricles, ... amount of CSF surrounding the brain changes significantly. ...
(Date:11/30/2016)... 2016 Varian Medical Systems (NYSE: ... JUST Company in the Healthcare Equipment and Services industry, ... inaugural "JUST 100 List." The rankings are based on ... conducted on attitudes towards corporate behavior, involving 50,000 Americans ... U.S companies against their peers within 32 major industries. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... Rijuven ... stress and overall health, day and night. No other wearable health technology on the ... We wanted to give poeple more meaningful insights about their health than the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On ... individuals and families from eight different sites throughout Miami-Dade and Broward counties. This ... volunteers worked very hard on Thanksgiving morning by putting together individual meals via ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... have been designated as a Cigna Infertility Center of Excellence. The Cigna Center ... , “It’s an honor to be designated a Cigna Infertility Center of ...
(Date:11/30/2016)... FL (PRWEB) , ... November 30, 2016 , ... ... disorder and mental health treatment has announced the opening of a new eating ... partial hospitalization and intensive outpatient treatment for adults and adolescents, both males and ...
Breaking Medicine News(10 mins):